Objective To investigate the value of digital rectal examination(DRE) and transrectal ultrasonography(TRUS) for prostate cancer diagnosis in subjects with prostate specific antigen(PSA) levels of 4.0 ng/ml or less.Methods 112 subjects with PSA levels of 4.0 ng/ml or less and abnormal findings on DRE or TRUS underwent prostate biopsy.The subjects were divided into four groups according to PSA levels:0 to 0.9 ng/ml,1.0 to 1.9 ng/ml,2.0 to 2.9 ng/ml,and 3.0 to 4.0 ng/ml.The reliability of DRE and TRUS and clinicopathologic features of prostate cancer were investigated in these four groups.Results Of the 112 subjects,14 (12.5%) were diagnosed as having prostate cancer.There was 0,2,5,and 7 patients in subjects of the four groups,respectively. The detection rate of abnormal findings on DRE and TRUS in subjects with PSA levels of 0 to 1.9 ng/ml and 2.0 to 4.0ng/ml was 5% vs 21.1%(P0.05 ) and 2.4%vs 28.6%(P0.05),respectively.Adding TRUS to DRE in the screening program of subjects with PSA levels of 2.0 to 4.0 ng/ml increased the detection rate of prostate cancer to 40%(4 of 10).Conclusions Routine prostate biopsy should not be undertaken except for highly suspicious DRE findings in subjects with PSA levels less than 2.0 ng/ml.The additional use of TRUS in subjects with PSA levels of 2.0 to 4.0 ng/ml would improve the sensitivity of prostate cancer detection.The diagnostic algorithm proposed in the present study is useful as a screening method for prostate cancer in subjects with PSA levels of 4.0 ng/ml or less.